Cargando…
Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients
OBJECTIVES: 1) review benefits and risks of cannabis use, with emphasis on otolaryngic disease processes; 2) define and review the endocannabinoid signaling system (ESS); and 3) review state and federal regulations for the use and research of cannabis and ESS modulators. METHODS: This manuscript is...
Autores principales: | Bryant, Lucas M., Daniels, Kelly E., Cognetti, David M., Tassone, Patrick, Luginbuhl, Adam J., Curry, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057224/ https://www.ncbi.nlm.nih.gov/pubmed/30062131 http://dx.doi.org/10.1002/lio2.154 |
Ejemplares similares
-
Mobile applications in otolaryngology for patients: An update
por: Casale, Manuele, et al.
Publicado: (2018) -
Experience with key indicator cases among otolaryngology residents
por: O'Brien, Daniel C., et al.
Publicado: (2019) -
A study of otolaryngology resident quality of life and sleepiness
por: Garcia‐Rodriguez, Laura R., et al.
Publicado: (2017) -
Cost savings associated with an outpatient otolaryngology telemedicine clinic
por: Philips, Ramez, et al.
Publicado: (2019) -
The Impact of COVID-19 on Otolaryngology Community Practice in Massachusetts
por: Fan, Timothy, et al.
Publicado: (2021)